# Contrast-Enhanced Ultrasound vs Conventional US-guided Percutaneous Needle Biopsy for Pancreatic Diseases: Prospective Multicenter Randomized Controlled Trial

> **NCT05743972** · NA · UNKNOWN · sponsor: **xiao-yan xie** · enrollment: 196 (estimated)

## Conditions studied

- Pancreatic Disease

## Interventions

- **DIAGNOSTIC_TEST:** Contrast-enhanced ultrasound-guided core biopsy
- **DIAGNOSTIC_TEST:** Conventional ultrasound-guided core biopsy

## Key facts

- **NCT ID:** NCT05743972
- **Lead sponsor:** xiao-yan xie
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-01
- **Primary completion:** 2025-12-01
- **Final completion:** 2026-02-01
- **Target enrollment:** 196 (ESTIMATED)
- **Last updated:** 2023-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05743972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05743972, "Contrast-Enhanced Ultrasound vs Conventional US-guided Percutaneous Needle Biopsy for Pancreatic Diseases: Prospective Multicenter Randomized Controlled Trial". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05743972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*